General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-08-08 | 2024-06 | -0.05 | N/A | N/A | N/A |
2024-05-14 | 2024-03 | -0.06 | -0.07 | -0.01 | -16.67% |
2024-03-28 | 2023-12 | -0.12 | -0.06 | 0.06 | 50.00% |
2023-11-09 | 2023-09 | -0.1 | -0.09 | 0.01 | 10.00% |
2023-08-10 | 2023-06 | -0.1 | -0.1 | N/A | N/A |
2023-05-11 | 2023-03 | -0.1 | -0.09 | 0.01 | 10.00% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-08-10 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-07-12 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-06-05 | HC Wainwright & Co. | Upgrade | Buy | |
2023-05-21 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-05-11 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-03-30 | HC Wainwright & Co. | Upgrade | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2016-10-02 | ARBUCKLE STUART A | Director | 5.64K | Stock Award(Grant) |
2017-01-02 | FRIEDMAN PAUL A | Director | 8.55K | Stock Award(Grant) |
2016-12-29 | GUIFFRE CHRISTOPHER D T | Chief Executive Officer | 12.49K | Stock Award(Grant) |
2019-04-10 | HAWLEY ROGER L | Director | 0.00 | Purchase |
2017-07-18 | JOHNSON SABRINA MARTUCCI | Chief Executive Officer | 0.00 | Stock Award(Grant) |
2017-01-02 | MCKEE WILLIAM T | Director | 3.42K | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 3.44M | 3.13M | 3.92% |
2023-06-29 | Geode Capital Management, LLC | 817.34K | 743.86K | 0.93% |
2023-06-29 | Renaissance Technologies, LLC | 718.82K | 654.20K | 0.82% |
2023-06-29 | Blackrock Inc. | 416.06K | 378.66K | 0.47% |
2023-06-29 | State Street Corporation | 247.71K | 225.44K | 0.28% |
2023-06-29 | Susquehanna International Group, LLP | 164.02K | 149.28K | 0.19% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 2.38M | 2.16M | 2.71% |
2023-06-29 | Vanguard Extended Market Index Fund | 942.15K | 857.45K | 1.07% |
2023-05-30 | Fidelity Extended Market Index Fund | 446.55K | 451.02K | 0.51% |
2023-05-30 | Fidelity Total Market Index Fund | 186.90K | 188.76K | 0.21% |
2023-08-30 | iShares Micro Cap ETF | 187.65K | 128.41K | 0.21% |
2023-06-29 | Price (T.Rowe) U.S. Equities Trust | 125.90K | 114.58K | 0.14% |
Split | Date |
---|---|
1 : 10 | 2017-07-20 |
Analyst Forecast
According to 11 analysts, the average rating for DARE stock is "Buy." The 12-month stock price forecast is 4.85, which is an increase of 284.92% from the latest price.
Price Target
$4.85
(284.92% upside)
Analyst Consensus: Buy
Chart
Bar chart with 5 bars.
The chart has 1 X axis displaying categories.
The chart has 1 Y axis displaying values. Data ranges from 0 to 8.
Stron
Analyst Forecast
According to 11 analysts, the average rating for DARE stock is "Buy." The 12-month stock price forecast is 7.34, which is an increase of 439.71% from the latest price.
Price Target
$7.34
(439.71% upside)
Analyst Consensus: Buy
Analyst Forecast
According to 11 analysts, the average rating for DARE stock is "Buy." The 12-month stock price forecast is 7.34, which is an increase of 487.20% from the latest price.
Price Target
$7.34
(487.20% upside)
Analyst Consensus: Buy
Analyst Forecast
According to 11 analysts, the average rating for DARE stock is "Buy." The 12-month stock price forecast is 7.34, which is an increase of 501.64% from the latest price.
Price Target
$7.34
(501.64% upside)
Analyst Consensus: Buy
Analyst Forecast
According to 11 analysts, the average rating for DARE stock is "Buy." The 12-month stock price forecast is 7.34, which is an increase of 599.05% from the latest price.
Price Target
$7.34
(599.05% upside)
Analyst Consensus: Buy
Average Analyst Ratings
3 MTHS AGO
Strong Buy
5.00
Based on 5 analysts
2 MTHS AGO
Strong Buy
5.00
Based on 6 analysts
1 MTH AGO
Strong Buy
5.00
Based on 5 analysts
CURRENT
Strong Buy
5.00
Based on 5 analysts
RATINGS VALUES: Strong Buy = 5 Moderate Buy = 4 Hold = 3 Moderate Sell = 2 Strong Sell = 1
Ratings Breakdown
3 MTHS AGO
Strong Buy
Based on 5 analysts
5 Strong Buy
2 MTHS AGO
Strong Buy
Based on 6 analysts
6 Strong Buy
Analyst Forecast
According to 11 analysts, the average rating for DARE stock is "Buy." The 12-month stock price forecast is 6.12, which is an increase of 303.96% from the latest price.
Price Target
$6.12
(303.96% upside)
Analyst Consensus: Buy
Tom weirdfield is a paid bear
Tom Fryfield is idiot and paid bear
Analyst price target for DARE
All Analysts
Top Analysts
Based on 2 analysts offering 12 month price targets for Dare Bioscience Inc.
Current
Analyst forecast
Jul '21
Jan '22
Jul '22
Jan '23
$0
$3
$6
$9
$12
2023-04-01● High: $11.00● Mean: $8.50● Low: $6.00
Min Forecast
$6.00+250.88%
Avg Forecast
$8.50+397.08%
Max Forecast
$11.00+543.27%
HC Wainwright & Co. Maintains Buy on Dare Bioscience, Raises Price Target to $6
https://www.benzinga.com/news/22/04/26421858/hc-wainwright-co-maintains-buy-on-dare-bioscience-raises-price-target-to-6 https://www.benzinga.com/news/22/04/26421858/hc-wainwright-co-maintains-buy-on-dare-bioscience-raises-price-target-to-6
Analyst Forecast
According to 11 analysts, the average rating for DARE stock is "Buy." The 12-month stock price forecast is 6.12, which is an increase of 247.73% from the latest price.
Price Target
$6.12
(247.73% upside)
Analyst Consensus: Buy
Stock Price Forecast
The 5 analysts offering 12-month price forecasts for Dare Bioscience Inc have a median target of 6.00, with a high estimate of 17.00 and a low estimate of 3.00. The median estimate represents a +248.84% increase from the last price of 1.72.
Analyst Recommendations
The current consensus among 5 polled investment analysts is to buy stock in Dare Bioscience Inc. This rating has held steady since January, when it was unchanged from a buy rating.
Move your mouse over past
months for detail
Earnings and Sales Forecasts
Current QuarterEarnings per Share
-$0.14Sales
$437.8KReporting Date
May 18
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.
Growthquarterly -29.55%
Growthannually 22.54%
Sales
Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.
U.S
Crime + Justice
Energy + Environment
Extreme Weather
Space + Science
World
Africa
Americas
Asia
Australia
Europe
Middle East
UK
Politics
45
Congress
Supreme Court
2018
Key Races
Primary Results
Business
Markets
Tech
Media
Success
Video
Opinion
Political Op-Eds
Social Commentary
Health
Food
Fitness
Wellness
Parenting
Vital Signs
Entertainment
Stars
Screen
Binge
Culture
Media
Tech
Innovate
Gadget
Mission: Ahead
Upstarts
Innovative Cities
Style
Arts
Design
Fashion
Architecture
Luxury
Autos
Video
Travel
Destinations
Food & Drink
Play
Stay
Videos
Sports
Pro Football
College Football
Basketball
Baseball
Soccer
Olympics
Video
Live TV
Digital Studios
CNN Films
HLNTV
Schedule
TV Shows A-Z
CNNVR
Shop
CNN Underscored
-Explore
-Wellness
-Gadgets
-Lifestyle
CNN Store
More...
Photos
Longform
Investigations
CNN Profiles
CNN Leadership
CNN Newsletters
Work for CNN
Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer. Morningstar: 2019 Morningstar, Inc. All Rights Reserved. Factset: FactSet Research Systems Inc.2019. All rights reserved. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices
S&P Dow Jones Indices LLC 2019 and/or its affiliates.
2021 Cable News Network. A Warner Media Company. All Rights Reserved.
CNN Sans &
2016 Cable News Network.
Newsletters
Contact Us
Terms of Use
Privacy Policy
Do Not Sell My Personal Information
Accessibiliy & CC
AdChoices
According to 11 analysts, the average rating for DARE stock is "Buy." The 12-month stock price forecast is 6.12, which is an increase of 275.46% from the latest price.
Price Target
$6.12
(275.46% upside)
Analyst Consensus: Buy
HC Wainwright & Co. Maintains Buy on Dare Bioscience, Raises Price Target to $6
https://www.benzinga.com/news/22/04/26421858/hc-wainwright-co-maintains-buy-on-dare-bioscience-raises-price-target-to-6 https://www.benzinga.com/news/22/04/26421858/hc-wainwright-co-maintains-buy-on-dare-bioscience-raises-price-target-to-6
Daré Bioscience (NASDAQ:DARE) PT Raised to $17.00 at Roth Capital
Daré Bioscience logoDaré Bioscience (NASDAQ:DARE - Get Rating) had its price target hoisted by equities researchers at Roth Capital from $11.00 to $17.00 in a note issued to investors on Friday, The Fly reports.
Several other brokerages have also commented on
Question : can DARE beats estimates on earning in 9 days ??